TIG Advisors LLC’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

TIG Advisors LLC’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,279,595	Closed	-$12.8M	–	75
2023 Q4	$12.8M	Buy	+1,279,595	New	+$5.81M	1.6%	13

TIG Advisors LLC's GRCL Position: Q1 2024 in Review

TIG Advisors LLC sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 1,279,595 shares — an estimated $12.8M sold.

TIG Advisors LLC first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $12.8M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

TIG Advisors LLC reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
TIG Advisors LLC sold 1,279,595 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $12.8M.
TIG Advisors LLC first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
TIG Advisors LLC's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $12.8M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on TIG Advisors LLC's 13F filing for Q1 2024, filed 15 May 2024.